Biocatalysis for pharmaceuticals - Status and prospects for a key technology

Metabolic Engineering

Volumn 2, Issue 1, 2000, Pages 42-48

  Buckland, Barry C ^a   Robinson, David K ^a   Chartrain, Michel ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033943997     PISSN: 10967176     EISSN: None     Source Type: Journal    
DOI: 10.1006/mben.1999.0138     Document Type: Article

References (16)

1. Blacker A., Holt R. Collins A. N. Chirality in Industry II. 1997;Wiley, New York.
2. Buckland B. C., Dunnill P., Lilly M. D. Biotechnol. Bioeng. 17:1975;815-826.
3. Buckland B. Metab. Eng. I:1999;63-74.
4. Chartrain M., White R., Goegelman R., Gbewonyo K., Greasham R. J. Ind. Microbiol. 6:1990;279-284.
5. Chartrain, M, Katz, L, and, King, S. A. 1995. U.S. Patent 5, 474, 919.
6. Gbewonyo K., Buckland B. C., Lilly M. D. Biotechnol. Bioeng. 37:1991;1101-1107.
7. Khosla C., Zawada R. J. X. Trends Biotechnol. 14:1996;335-341.
8. Kragl U., Kruse W., Hummel W., Wandrey C. Biotechnol. Bioeng. 52:1996;309-319.
9. McCoy, M.1999. Chemical and Engineering News, January 4, 1999, pp. 10-14.
10. Persidis A. Nature Biotechnol. 15:1997;594.
11. Reddy J., Tschaen D., Shi Y. J., Pecore V., Katz L., Greasham R., Chartrain M. J. Ferm. Bioeng. 81:1996;304-309.
12. Roberge C., Cvetovich R., Amato J., Pecore V., Hartner F., Greasham R., Chartrain M. J. Ferm. Bioeng. 83:1997;48-53.
13. Self D. A., Kilburn D. G., Lilly M. D. Biotechnol. Bioeng. 10:1968;829-843.
14. Stephanopoulos G. Metab. Eng. I:1999;1-11.
15. Woodley J. M., Lilly M. D. Cabral. Applied Biocatalysis. 1994;Harwood Academic.
16. Zaks A., Dodds D. DDT. 2:1997;513-531.